Morning Overview on MSN
A pancreatic cancer drug nearly doubled survival in a late-stage trial of 500 patients
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an experimental daily ...
A phase 1b/2, multicenter, open-label study to evaluate the efficacy and safety of GSK5764227 (GSK’227), alone and in combination in patients with previously treated advanced unresectable or ...
Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...
Medical research is essential for advancing the understanding of health, diseases, and treatments. There are many types of studies that serve different purposes. Medical research, or health research, ...
We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving adults with acute, nonarteritic central retinal artery occlusion who had symptom onset within 4.5 hours ...
Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the completion of planned enrollment ...
Radiographic progression free survival (RECIST 1.1 and PCWG3) CTCAE v5.0 ...
As cell and gene therapies (CGTs) continue to advance, they have unique developmental features that may require innovation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results